Sports Brand Supports Germany’s High-Goal Polo Event for Sixth Consecutive Year BERLIN, GERMANY AND WEST PALM BEACH, FL / ACCESS Newswire / September 16, 2025 / U.S. Polo Assn., the …
Latest in ACCESS Newswire
-
-
ACCESS Newswire
GA-ASI and AeroVironment Complete First-Ever Air Launch of Switchblade 600 From MQ-9A UAS
Release of Smaller Loitering Munition Further Validates Large UAS as Motherships SAN DIEGO, CALIFORNIA / ACCESS Newswire / September 10, 2025 / General Atomics Aeronautical Systems, Inc. (GA-ASI) and AeroVironment …
-
Veteran Investment Executive to Lead Dubai-Based Platform’s Multi-Strategy Expansion DUBAI, AE / ACCESS Newswire / September 8, 2025 / General Holdings Limited, a diversified investment platform headquartered in Dubai International …
-
ACCESS Newswire
U.S. Polo Assn. Celebrates Historic Title Sponsorship of 2025 Pacific Coast Open at Santa Barbara Polo & Racquet Club
Global Sports Brand Marks Eighth Year Partnering with the Iconic West Coast Polo Club SANTA BARBARA, CA AND WEST PALM BEACH, FL / ACCESS Newswire / September 4, 2025 / …
-
ACCESS Newswire
Phase 1 Clinical Ttrial of HIV Vaccine Starts in Africa to Evaluate Immune Responses to Highly Networked HIV T-Cell Epitopes
Led by a team of African researchers, first doses of the novel T cell-inducing GRAdHIVNE1 vaccine candidate have been given. HARARE, ZIMBABWE, ROME, ITALY, NEW YORK, NY, AND CAMBRIDGE, MA …
-
Leader in AI-ready data management establishes Middle East operations in UAE and Saudi Arabia, appoints industry veteran Kunwar Khehar to lead regional growth PALO ALTO, CA / ACCESS Newswire / …
-
ACCESS Newswire
Saudi Travel Platform almatar Reports 30% Surge in Risk Mitigation Services Amid Regional Airspace Disruption
RIYADH, SA / ACCESS Newswire / June 20, 2025 / Amid a major regional crisis that led to the sudden closure of airspace across more than 20 airports and the …
-
ACCESS Newswire
IAVI and Biofabri/Zendal Announce First Vaccinations in the IMAGINE Clinical Trial, a Large-scale Safety and Efficacy Trial of the Tuberculosis Vaccine Candidate MTBVAC
Tuberculosis (TB) is the world’s deadliest infectious disease, killing 1.25 million people in 2023. MTBVAC is a promising vaccine candidate being evaluated in the IMAGINE trial, a large-scale safety and …
-
TOKYO, JP / ACCESS Newswire / February 5, 2025 / From 2 p.m. to 4 p.m. on Jan. 29, Blackbox held its first in-house media event. We were aiming to …
-
WATERLOO, ON and EDEN PRAIRIE, MN / ACCESS Newswire / February 3, 2025 / Arctic Wolf® and BlackBerry Limited (NYSE:BB)(TSX:BB), two global leaders in security software and services, today announced …